Home › Funds › Integral Health Asset Management, LLC › EW
Integral Health Asset Management, LLC position in EW
EDWARDS LIFESCIENCES CORP · Health Care
Integral Health Asset Management, LLC reported holding 200,000 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$17.3M, representing 1.12% of its reported portfolio and ranking #29 among its reported holdings. Integral Health Asset Management, LLC has disclosed EW holdings in 8 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Integral Health Asset Management, LLC's EW position evolved
Integral Health Asset Management, LLC first disclosed a stake in EW in Q2 2024 at 150,000 shares (US$13.9M). The position peaked in Q2 2026 at 625,000 shares, worth US$56.5M. Across 8 filings, Integral Health Asset Management, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 200,000 shares valued at US$17.3M — a reduction of -425,000 shares quarter over quarter.. Notable position changes include a 62% increase in Q4 2025 (shares fell 6% over the following quarter), a 268% increase in Q2 2026 (shares fell 5% over the following quarter), a 68% trim in Q3 2026 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 150.00K | $13.86M | New |
| Q1 2025 | 125.00K | $9.06M | New |
| Q2 2025 | 200.00K | $15.64M | Add |
| Q3 2025 | 200.00K | $15.55M | Hold |
| Q4 2025 | 325.00K | $27.71M | Add |
| Q1 2026 | 170.00K | $13.61M | Reduce |
| Q2 2026 | 625.00K | $56.54M | Add |
| Q3 2026 | 200.00K | $17.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 29 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- Belvedere Trading LLC 3.30M sh · $25.63B · Q3 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Arrowstreet Capital 10.19M sh · $879.93M · Q3 2026
- Aristotle Capital Management, LLC 8.12M sh · $700.72M · Q3 2026
- BROWN ADVISORY INC 6.46M sh · $557.32M · Q3 2026
- Artisan Partners Limited Partnership 6.09M sh · $525.69M · Q3 2026
More on Integral Health Asset Management, LLC
FAQ
How long has Integral Health Asset Management, LLC held EW?
Integral Health Asset Management, LLC has disclosed EW holdings in 8 of the last 10 reported quarters, going back to Q2 2024.
What is Integral Health Asset Management, LLC's current position in EW?
As of Q3 2026, Integral Health Asset Management, LLC holds 200.00K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $17.26M, representing 1.12% of its reported portfolio and ranking #29.
Has Integral Health Asset Management, LLC been buying or selling EW?
In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC reduced its position in EW. The position peaked in Q2 2026 at 625.00K shares.
Which other funds hold EW?
Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.